Long-term Outcomes in Patients With COVID-19
Status
Conditions
Details and patient eligibility
About
Long-term outcomes from coronavirus disease 2019 (COVID-19) are currently unknown. This study will collect daily living status of survivors of COVID-19.
Full description
The ongoing pandemic of coronavirus disease 2019 (COVID-19), due to the newly discovered severe acute respiratory syndrome coronavirus 2 (SAR-CoV-2), has caused a worldwide increase in hospitalization for pneumonia with multi- organ disease. Survival from sepsis is associated with increased risk for mortality for at least 2 years. Therefore, substantial sequelae including new physical disability, new cognitive impairment and increased vulnerability to further health deterioration are likely to be seen in survivors of COVID-19. The investigators conduct this study to investigate daily living status of survivors of COVID-19 using telephone interview questionnaire including Activity Daily Living(ADL), modified Medical Research Council(mMRC),modified Telephone Interview for Cognitive Status (TICS-m), Zung Self-rating Depression Scale(SDS), Carcinologic Handicap Index (CHI), and New York Heart Association (NYHA) functional class.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Survivors who had been admitted in Leishenshan Hospital for COVID-19 patients in Wuhan, China
Exclusion criteria
- Patients who were < 18 years
Trial contacts and locations
Loading...
Central trial contact
Diansan Su, MD,PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal